Skip to content

M Spitzer

3 papers in the library · publishing 1993-2001

Papers

Sort Most recent Most cited

Enantio-selective cognitive and brain activation effects of N-ethyl-3,4-methylenedioxyamphetamine in humans.

Neuropharmacology August 2001 M Spitzer, B Franke, H Walter et al.

In a randomised double-blind trial the subjective, neuropsychological and brain activation effects of the two enantiomers of the MDMA (ecstasy-) like drug N-ethyl-3,4-methylenedioxyamphetamine (MDE) were studied in five normal subjects using functional magnetic resonance imaging (fMRI). (S)-MDE produced elevated mood, impairments in conceptually driven cognition and marked right frontal...

[Hallucinogen induced psychic disorders. Subjective experiences, psychopathology and differential diagnosis].

Fortschritte der Neurologie-Psychiatrie December 1996 L Hermle, E Gouzoulis-Mayfrank, M Spitzer

The concepts of intoxication, intoxication psychosis, and drug-induced psychosis are frequently used to refer to psychopathological states caused by the intake of hallucinogenic substances. The considerable increase of intoxications with substances of the chemical class of amphetamines (in particular, "Ecstasy") in western countries should cause major concern. Moreover, the number of...

Psychological effects of MDE in normal subjects. Are entactogens a new class of psychoactive agents?

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology February 1993 L Hermle, M Spitzer, D Borchardt et al.

The so-called entactogens 3,4-methylenedioxymethamphetamine ([MDMA] also known as "Ecstasy," or "Adam") and its analog 3,4-methylenedioxyethamphetamine ([MDE] also known as "Eve") exert similar psychotropic effects in humans. Two double-blind placebo-controlled psychometric studies with normal control subjects were conducted. Placebo or MDE (140 mg) was administered orally to eight male...